Friday 6 November 2026 Export WST’s income statement to Excel — free account

West Pharmaceutical Services, Inc.

WST Healthcare Medical Instruments & Supplies

West Pharmaceutical Services, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $3.1 billion, up 6.25% from fiscal 2024.

Revenue: +8.69%
EPS: +56.7%
Free cash flow: +12.3%
Total debt: +0.10%

Quarter to September 2026, against a year earlier

392.97 15.81 −3.87%

Follow WST

Alert me

Market cap: $27.3B
P/E: 43.8×
Fwd P/E: 48.1×
Dividend yield: 0.22%
F-score: 8/9
Altman Z: 13.89
Beneish M: −2.79
Dividend safety: 100/100

Overview Business Profile Earnings & Analysis Segments Valuation Filings

	Sep '26	Jun '26	Mar '26	Dec '25	Older periods
Piotroski F-Score Full definition →	8	9	8	8	+8 more TTM periods Free account
ROE Full definition →	21.23%	19.09%	19.13%	16.85%
ROA Full definition →	15.65%	14.07%	14.05%	12.48%
ROIC Full definition →	18.01%	15.42%	15.32%	14.13%
Return on Tangible Assets Full definition →	22.46%	19.80%	19.01%	16.19%
Average Days of Receivables Full definition →	80.40	78.12	77.69	68.20
Free Cash Flow per Share Full definition →	6.44	6.17	6.36	6.49
Free Cash Flow Full definition →	453.40	436.90	458.00	468.90
Capital Expenditures Full definition →	(201.10)	(225.30)	(257.30)	(285.90)
Other line items
Cash ROIC Full definition →	12.47%	12.04%	12.33%	11.24%
Accounts Receivable Turnover Full definition →	4.95	5.14	5.24	5.46
Accounts Payable Turnover Full definition →	8.39	8.55	8.54	7.99
Inventory Turnover Full definition →	4.70	4.84	4.88	4.80
Average Days of Payables Full definition →	42.94	43.86	44.87	47.00
Days of Inventory on Hand Full definition →	80.01	77.65	80.49	82.24
Tax Rate Full definition →	(0.21)	(0.21)	(0.21)	(0.20)
Research and Development Expense of Revenue Full definition →	2.23%	2.24%	2.29%	2.42%
Selling, General and Administrative Expense of Revenue Full definition →	12.87%	12.83%	12.58%	12.80%
Share Based Compensation of Revenue Full definition →	0.84%	0.98%	0.90%	0.77%
Interest Coverage Full definition →	96.32	151.20	327.50	1,169.80
Operating CF/Net income Full definition →	1.02	1.17	1.32	1.53
Depreciation/Fixed assets Full definition →	0.11	0.11	0.10	0.10
Capex/Depreciation Full definition →	(1.09)	(1.24)	(1.46)	(1.67)
Revenue per Share Full definition →	48.25	46.99	44.74	42.52
Operating CF per Share Full definition →	9.30	9.35	9.93	10.44
Capex per Share Full definition →	(2.86)	(3.18)	(3.57)	(3.95)
Capex to Sales Full definition →	0.06	0.07	0.08	0.09

Show all line items

Columns are period end dates · fundamentals updated 2 Nov 2026

Stockrow Weekly